Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Hand-Based therapy ease COPD's toughest symptoms?

NCT ID NCT07746596

Symptom relief Sponsor: Erzincan Binali Yildirim Universitesi Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 05, 2026 · Last updated Aug 11, 2026 · Updated 3 times

Summary

This trial investigates whether Su Jok therapy, a complementary technique that stimulates specific points on the hands, can reduce dyspnea (breathlessness) and fatigue in people with chronic obstructive pulmonary disease (COPD). The study will include 30 hospitalized adults with COPD who will receive Su Jok therapy daily for five days alongside their usual care. Researchers will measure changes in symptom severity using visual analog scales. The goal is to see if this safe, non-invasive approach can offer additional relief and improve quality of life for COPD patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Su Jok therapy, a hand-based complementary technique involving stimulation of specific points on the hands
What this could lead to
If effective, Su Jok therapy could offer a safe, drug-free way to help COPD patients manage breathlessness and fatigue, potentially improving their quality of life.
What could go wrong
This is a small, early-stage trial with only 30 participants, so results may not apply broadly. The therapy's benefits are uncertain, and it is not a replacement for standard COPD treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Jan 2026

Finished

Aug 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older. * Diagnosed with chronic obstructive pulmonary disease (COPD). * Able to communicate verbally. * Expected to remain hospitalized for at least 5 days to ensure completion of the intervention. * No major health condition other than COPD that could adversely affect activities of daily living (e.g., open wounds, cancer, or gastrointestinal disorders). * Provided written informed consent to participate in the study. * A Visual Analog Scale (VAS) score of 3 or higher for dyspnea and fatigue. Exclusion Criteria: * Declined or were unable to provide written informed consent. * Unable to communicate verbally. * Conditions preventing the application of Su Jok therapy to the hands, including neuropathy, amputation, open wounds, or other hand disorders.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive lung disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease Dyspnea Fatigue

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive lung disease Dyspnea Fatigue symptom

Contacts and locations

Locations

  • Erzincan Binali Yıldırım University

    Erzincan, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.